Goto, Fuki
Kawakita, Fumihiro
Hakozaki, Koichi
Aoki, Kazuaki
Suzuki, Hidenori https://orcid.org/0000-0002-8555-5448
,
Sakaida, Hiroshi
Umeda, Yasuyuki
Tanaka, Katsuhiro
Miura, Yoichi
Kamei, Yusuke
Sano, Takanori
Araki, Tomohiro
Shiba, Masato
Ichikawa, Naoki
Shimizu, Shigetoshi
Tsuchiya, Takuro
Asada, Reona
Toma, Naoki
Yasuda, Ryuta
Nakatsuka, Yoshinari
Nishikawa, Hirofumi
Kanamaru, Hideki
Kitano, Yotaro
Ishida, Fujimaro
Fukazawa, Keiji
Tanioka, Satoru
Tsuda, Kazuhiko
Sato, Yu
Murata, Hiroto
Hamada, Kazuhide
Miya, Fumitaka
Tanemura, Hiroshi
Fujimoto, Masashi
Article History
Received: 1 September 2025
Revised: 2 November 2025
Accepted: 8 November 2025
First Online: 21 November 2025
Declarations
:
: Dr. Suzuki reported personal fees from Eisai, Kowa, Otsuka and Nxera Pharma, and a research fund from Japan Blood Products Organization and Nxera Pharma outside the submitted work. The other authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of Mie University Hospital (May 14, 2013; approval No. 2544, and September 6, 2018; approval No. H2018-031).
: not applicable.
: The ethical committee waived the need for informed consent with opt-out.